Yuanzhen Chen
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 26, 2022
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.Shengnan Cao, Guangjian Hou, Ya Meng
|May 16, 2022
Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury.Haojun Shi, Liangyu Xie, Wenchang Xu
|Jan 27, 2022
Decreased Adiponectin Levels Are a Risk Factor for Cognitive Decline in Spinal Cord Injury.Fan-Jie Liu, Hong-Hao Xu, Ying Yin
|Dec 08, 2021
Expression of ANGPTL4 in Nucleus Pulposus Tissues Is Associated with Intervertebral Disc Degeneration.Fan-Jie Liu, Liang-Yu Xie, Hua-Zhong Li
|Nov 22, 2021
Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury.Shifei Sun, Shilong Sun, Yan Meng
|Oct 22, 2021
Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells.Xiaoxun Du, Xiaoying Wang, Kaiying Cui
Pageof 2
